ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,980.19
-1.19%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) Quote

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
14.15
0.33
(2.39%)
Closed April 27 4:00PM
Delayed by 15 minutes
14.15
0.00
(0.00%)
After Hours: 4:25PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
14.15
Bid
12.00
Ask
16.14
Volume
135,619
13.69 Day's Range 14.32
8.69 52 Week Range 24.13
Market Cap
483.169M
Previous Close
13.82
Open
13.97
Last Trade
50
@
14.42
Last Trade Time
Financial Volume
$ 1,902,847
VWAP
14.0308
Average Volume (3m)
370,601
Shares Outstanding
34,122,087
Dividend Yield
-
PE Ratio
-4.73
Earnings Per Share (EPS)
-3
Revenue
82.71M
Net Profit
-102.24M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.urogen.com
Headquarters
Ra'anana, Center, Isr
Founded
1970
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $13.82. Over the last year, UroGen Pharma shares have traded in a share price range of $ 8.69 to $ 24.13.

UroGen Pharma currently has 34,122,087 shares outstanding. The market capitalization of UroGen Pharma is $483.17 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.73.

URGN Latest News

More News

UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers

Subgroup analysis of the UGN-102 ATLAS Trial in patients with new versus recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) Three independent long-term...

April 17 2024
Business Wire

UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

UroGen plans to initiate a Phase 3 study to explore the safety and efficacy of UGN-103 in 2024 Anticipated advantages include a new 80 mg mitomycin dosage strength that may considerably shorten...

April 15 2024
Business Wire

UroGen Pharma Files Patent Infringement Action Against Teva Pharmaceuticals

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced that it has filed a...

April 03 2024
Business Wire

UroGen Pharma Delivers Double Digit JELMYTO® Growth and Prepares for the Next Phase of the Company with on Track Rolling Submission of UGN-102

Initiated submission of a rolling NDA to the FDA for UGN-102; 12-month duration of response data from ENVISION expected to support completion of NDA submission Announced next-generation novel...

March 14 2024
Business Wire

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of...

March 08 2024
Business Wire

UroGen Pharma to Report Fourth Quarter and Full-Year 2023 Financial Results on Thursday, March 14, 2024

Conference Call and Webcast Scheduled for Thursday, March 14, 2024, at 10:00 AM ET UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative...

March 04 2024
Business Wire

Form 8-K - Current report

March 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 01 2024
Edgar (US Regulatory)

UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference

- Presentation March 4, 2024 at 1:30 PM ET - UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...

February 26 2024
Business Wire

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

February 12 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.090.64011379800914.0614.8513.1723343614.08552059CS
4-0.6-4.0677966101714.7515.512.3730611014.25744913CS
12-1.6-10.158730158715.7519.8712.3737060116.22426532CS
262.8625.332152347211.2919.8710.6331660215.15567433CS
522.5321.772805507711.6224.138.6937982316.13026703CS
156-5.46-27.842937276919.6124.134.8520571814.05267493CS
260-22.88-61.787739670537.0339.974.8519941818.54718496CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
jerrybrockman jerrybrockman 4 minutes ago
Are you Armenian? If so, then I have great respect for your suffering. You have no idea the level at which I understand it.
Someone is targeting every one of my posts with clown, Jew, monkey. What am I supposed to do? Do me a favor, help me find the $&&))?;:er.
TGLO
grantastic grantastic 4 minutes ago
"Obviously couldn't provide specifics" because HDUP is a defunct scam ticker that's not conducting any bona fide business.

'things' for HDUP are perpetually 'unfolding' to a conclusion that will never appear, like a fractal image. There's always another development just about to be r
HDUP
GRIMREAPER3 GRIMREAPER3 5 minutes ago
Hey Buttercup, why are you bashing anybody pointing of this company's EGREGIOUSLY MASSIVE missing links? If you love it SO MUCH to defend it, why do you NEVER EVER extol its virtues and recommend it as is a great "investment"?? How strange. You never do ANYTHING to promote it, LET ALONE SUPPORT IT
PHBI
Methinks Methinks 9 minutes ago
More marketing - on Linkedin - https://metalert.com/hands-free-tele-health/
MLRT
eagle8 eagle8 10 minutes ago
Together they form a large platform!

GLTU
NWBO
jeunke22 jeunke22 13 minutes ago
Yes Lewrock that’s the first law of holes: "if you find yourself in a hole, stop digging".
The second law of holes is commonly known as: "when you stop digging, you are still in a hole."
Mind you these guys keep on digging until they get to the other side of the globe, if they don’t p
LWLG
SphinxMaestro91 SphinxMaestro91 14 minutes ago
https://www.craftyartapp.com/k/baby-shower-invitations Baby shower invitations are more than just pieces of paper; they set the tone for the entire event. Whether you're planning a whimsical affair or a sophisticated gathering, your invitation gives guests a glimpse into what to expect.
SphinxMaestro91 SphinxMaestro91 17 minutes ago
[url=https://www.craftyartapp.com/k/baby-shower-invitations]Baby shower invitations Baby shower invitations are more than just pieces of paper; they set the tone for the entire event. Whether you're planning a whimsical affair or a sophisticated gathering, your invitation gives guests a glimpse in
Investor2014 Investor2014 17 minutes ago
There is precious little of what you post that is a must see, most is a best ignore!
AVXL
SphinxMaestro91 SphinxMaestro91 19 minutes ago
[url=https://www.craftyartapp.com/k/baby-shower-invitations]Baby shower invitations insert-text-here are more than just pieces of paper; they set the tone for the entire event. Whether you're planning a whimsical affair or a sophisticated gathering, your invitation gives guests a glimpse into what
fuagf fuagf 24 minutes ago
Sarah McLachlan. The song and the woman, a beautiful pair.
grantastic grantastic 26 minutes ago
You can look in the mirror when asking that question. Let us know when you have an answer.

Why are you here if you don’t like the stock?
APRU
fuagf fuagf 27 minutes ago
Has a feeling that might have been the case.
fuagf fuagf 29 minutes ago
She really does come across as lame.
Rodney5 Rodney5 29 minutes ago
Glen, I appreciate you taking the time to call out Calabria. Quote: “ So if FHFA is not an independent agency then how does the SPSPA work? The government just signs deals with itself now?”

I encourage you to repent start publishing the truth on your Seeking Alpha. Quit fighting the
FNMA
MadBrewer MadBrewer 32 minutes ago
My guess is,...what's next here??,..
"I’m waiting for some kind of clarification on “if/where the profits are ??"
the "up til 9 months" part sunk this.

Either way,...you hyped Taylor Swift & that was the rocket YET,..
show no profit,....until 9 months??
ABQQ
frrol frrol 33 minutes ago
I think he means "getting" as "in the process of getting".
AVXL
Mdk1 Mdk1 33 minutes ago
Fully agree. Should this prove to be a false downside breakout your timing would indeed be perfect jeunke !
Moreover, a false breakout to the downside followed by a move back into the pattern often signals a potential shift in momentum. Think about it, ASM in a couple of weeks … This eve
ASM
shajandr shajandr 34 minutes ago
Here is the reason: you are very badd at the investing thing.

Hold for the total loss here.
FUNN
misterfishman misterfishman 35 minutes ago
He,s got rocks in the brain.
IGPK
misterfishman misterfishman 35 minutes ago
He,s got rocks in the brain.
IGPK
misterfishman misterfishman 37 minutes ago
Damn this is getting harder as I get older I don't recover at 60 as I did at 30 it takes so much longer if my doc would prescribed me some steroids then no problem but nooo stay natural she says I would like to see her hubby come and bench 245 pounds at 60 years old.
IGPK
Rodney5 Rodney5 44 minutes ago
You are publishing lies!

Mr not so much wiseman said Quote: “ The placement in Conservatorship is the only lawful action.” End of Quote

When Paulson met with the directors of Fannie Mae and Freddie Mac to inform them of his intent to take over their companies, neithe
FNMA
gbb777 gbb777 44 minutes ago
Rumors are that Virtra is one whisker away from qualifying for the Russell 2000 index. Don't know if this is true, don't know if that will change anything.

Sold a bunch @ 15, bought back @ 12 couldn't resist.

VTSI

Your Recent History

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved